Evidence map›Paper›PMID 39232831›Full record

ArticleJournal of neuroengineering and rehabilitation2024

A new modular neuroprosthesis suitable for hybrid FES-robot applications and tailored assistance.

Javier Gil-Castillo, Diana Herrera-Valenzuela, Diego Torricelli, Ángel Gil-Agudo, Eloy Opisso, Joan Vidal, Josep M Font-Llagunes, Antonio J Del-Ama, Juan C Moreno

Abstract read
In one paragraph

Article in Journal of neuroengineering and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Javier Gil-CastilloBioRobotics Group, Center for Automation and Robotics, CSIC, Madrid, Spain.
Diana Herrera-ValenzuelaInternational Doctoral School, Rey Juan Carlos University, Madrid, Spain.
Diego TorricelliBioRobotics Group, Center for Automation and Robotics, CSIC, Madrid, Spain.
Ángel Gil-AgudoBiomechanics and Technical Aids Unit, National Hospital for Paraplegics, Toledo, Spain.
Eloy OpissoInstitut Guttmann, Institut Universitari de Neurorehabilitació adscrit a la UAB, Badalona, Barcelona, 08916, Spain.
Joan VidalInstitut Guttmann, Institut Universitari de Neurorehabilitació adscrit a la UAB, Badalona, Barcelona, 08916, Spain.
Josep M Font-LlagunesBiomechanical Engineering Lab, Department of Mechanical Engineering and Research Centre for Biomedical Engineering, Universitat Politècnica de Catalunya, Diagonal 647, Barcelona, 08028, Spain.
Antonio J Del-AmaBioengineering Systems and Technologies Research Group, Department of Applied Mathematics, Materials Science and Engineering and Electronic Technology, Rey Juan Carlos University, C/ Tulipan S/N, Móstoles, 28933, Spain.
Juan C MorenoBioRobotics Group, Center for Automation and Robotics, CSIC, Madrid, Spain. jc.moreno@csic.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo overcome the application limitations of functional electrical stimulation (FES), such as fatigue or nonlinear muscle response, the combination of neuroprosthetic systems with robotic devices has been evaluated, resulting in hybrid systems that have promising potential. However, current technology shows a lack of flexibility to adapt to the needs of any application, context or individual. The main objective of this study is the development of a new modular neuroprosthetic system suitable for hybrid FES-robot applications to meet these needs.

methodsIn this study, we conducted an analysis of the requirements for developing hybrid FES-robot systems and reviewed existing literature on similar systems. Building upon these insights, we developed a novel modular neuroprosthetic system tailored for hybrid applications. The system was specifically adapted for gait assistance, and a technological personalization process based on clinical criteria was devised. This process was used to generate different system configurations adjusted to four individuals with spinal cord injury or stroke. The effect of each system configuration on gait kinematic metrics was analyzed by using repeated measures ANOVA or Friedman's test.

resultsA modular NP system has been developed that is distinguished by its flexibility, scalability and personalization capabilities. With excellent connection characteristics, it can be effectively integrated with robotic devices. Its 3D design facilitates fitting both as a stand-alone system and in combination with other robotic devices. In addition, it meets rigorous requirements for safe use by incorporating appropriate safety protocols, and features appropriate battery autonomy, weight and dimensions. Different technological configurations adapted to the needs of each patient were obtained, which demonstrated an impact on the kinematic gait pattern comparable to that of other devices reported in the literature.

conclusionsThe system met the identified technical requirements, showcasing advancements compared to systems reported in the literature. In addition, it demonstrated its versatility and capacity to be combined with robotic devices forming hybrids, adapting well to the gait application. Moreover, the personalization procedure proved to be useful in obtaining various system configurations tailored to the diverse needs of individuals.

Indexed as

RoboticsSpinal Cord InjuriesAdultBiomechanical PhenomenaElectric Stimulation TherapyFemaleGaitHumansMaleMiddle AgedNeural ProsthesesProsthesis DesignStroke RehabilitationFunctional electrical stimulationGaitHybrid FES-exoskeletonKinematicsModular systemsNeuroprosthesesPersonalizationWearable exoskeletons

Identifiers

PMID39232831
PMCPMC11373245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.